Tien Liang BioTech Co., Ltd.

Taipei Exchange 4127.TWO

Tien Liang BioTech Co., Ltd. Price to Earnings Ratio (P/E) on January 14, 2025: 96.81

Tien Liang BioTech Co., Ltd. Price to Earnings Ratio (P/E) is 96.81 on January 14, 2025, a 17.59% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.
  • Tien Liang BioTech Co., Ltd. 52-week high Price to Earnings Ratio (P/E) is 102.66 on December 23, 2024, which is 6.04% above the current Price to Earnings Ratio (P/E).
  • Tien Liang BioTech Co., Ltd. 52-week low Price to Earnings Ratio (P/E) is 70.04 on August 05, 2024, which is -27.66% below the current Price to Earnings Ratio (P/E).
  • Tien Liang BioTech Co., Ltd. average Price to Earnings Ratio (P/E) for the last 52 weeks is 86.80.
Key data
Date Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S) Price to Book Ratio (P/B) Dividend Yield
Market news
Loading...
Taipei Exchange: 4127.TWO

Tien Liang BioTech Co., Ltd.

CEO Mr. Min-Chung Chi
IPO Date Dec. 31, 2007
Location
Headquarters No. 147, Datong Road
Employees 63
Sector Health Care
Industries
Description

Tien Liang BioTech Co., Ltd. manufactures and sells pharmaceutical products in Taiwan and internationally. The company offers Chinese medicine products, such as pills for liver and kidney deficiency, low back pain, sore feet, dizziness, thirst, dry tongue, sore throat, and heel pain, as well as rheumatism, joint pain, traveling pain, wind-cold-dampness, gout, neuralgia, enuresis, hemorrhoids, constipation, athlete's foot, fall injuries, cold, bronchitis, cough, and phlegm indications. It provides western medicine products, including ointment, hair removal cream, tablet, capsule, soreness spray, and pain patch products, as well as pain relief gels. In addition, the company offers healthcare products; and other products for body relaxation and comfort, and relieving discomfort after exercise, as well as tooth products and soaps. The company was founded in 1960 and is based in New Taipei City, Taiwan.

StockViz Staff

January 15, 2025

Any question? Send us an email